SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Olsson R, Danielsson A, Jarnerot G, Lindstrom E, Loof L, Rolny P, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology 1991; 100: 13191323.
  • 2
    Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995; 332: 924933.
  • 3
    Chapman RW. The management of primary sclerosing cholangitis. Curr Gastroenterol Rep 2003; 5: 917.
  • 4
    Lundqvist K, Broome U. Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study. Dis Colon Rectum 1997; 40: 451456.
  • 5
    Papatheodoridis GV, Hamilton M, Mistry PK, Davidson B, Rolles K, Burroughs AK. Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis. Gut 1998; 43: 639644.
  • 6
    Ho GT, Seddon AJ, Therapondos G, Satsangi J, Hayes PC. The clinical course of ulcerative colitis after orthotopic liver transplantation for primary sclerosing cholangitis: further appraisal of immunosuppression post transplantation. Eur J Gastroenterol Hepatol 2005; 17: 13791385.
  • 7
    Befeler AS, Lissoos TW, Schiano TD, Conjeevaram H, Dasgupta KA, Millis JM, et al. Clinical course and management of inflammatory bowel disease after liver transplantation. Transplantation 1998; 65: 393396.
  • 8
    Graziadei IW, Wiesner RH, Marotta PJ, Porayko MK, Hay JE, Charlton MR, et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999; 30: 11211127.
  • 9
    Verdonk RC, Haagsma EB, Van Den Berg AP, Karrenbeld A, Slooff MJ, Kleibeuker JH, Dijkstra G. Inflammatory bowel disease after liver transplantation: a role for cytomegalovirus infection. Scand J Gastroenterol 2006; 41: 205211.
  • 10
    Kane S, Kisiel J, Shih L, Hanauer S. HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease. Am J Gastroenterol 2004; 99: 15231526.
    Direct Link:
  • 11
    Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. B M J 1955; 4: 10411045.
  • 12
    Raftery M, Lang C, O'Shea J, Varghese Z, Sweny P, Fernando O, Moorhead J. Controlled trial of azathioprine and cyclosporin to prevent anti-HLA antibodies due to third-party transfusion. Nephrol Dial Transplant 1988; 3: 671675.
  • 13
    Rhodes JM, Collins P. Lessons for inflammatory bowel disease from rheumatology. Dig Liver Dis 2006; 38: 157162.
  • 14
    Ahmad T, Armuzzi A, Neville M, Bunce M, Ling KL, Welsh KI, et al. The contribution of human leucocyte antigen complex genes to disease phenotype in ulcerative colitis. Tissue Antigens 2003; 62: 527535.
  • 15
    Ahmad T, Satsangi J, McGovern D, Bunce M, Jewell DP. The genetics of inflammatory bowel disease [review]. Aliment Pharmacol Ther 2001; 15: 731748.
  • 16
    Silverberg MS, Mirea L, Bull SB, Murphy JE, Steinhart AH, Greenberg GR, et al. A population- and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic involvement in inflammatory bowel disease. Inflamm Bowel Dis 2003; 9: 19.
  • 17
    Yap LM, Ahmad T, Jewell DP. The contribution of HLA genes to IBD susceptibility and phenotype. Best Pract Res Clin Gastroenterol 2004; 18: 577596.
  • 18
    Neumann UP, Guckelberger O, Langrehr JM, Lang M, Schmitz V, Theruvath T, et al. Impact of human leukocyte antigen matching in liver transplantation. Transplantation 2003; 75: 132137.
  • 19
    Francavilla R, Hadzic N, Underhill J, Heaton N, Rela M, Mieli-Vergani G, et al. Role of HLA compatibility in pediatric liver transplantation. Transplantation 1998; 66: 5358.
  • 20
    Nelson JL, Hughes KA, Smith AG, Nisperos BB, Branchaud AM, Hansen JA. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med 1993; 329: 466471.
  • 21
    Nelson JL. Microchimerism and HLA relationships of pregnancy: implications for autoimmune diseases. Curr Rheumatol Rep 2001; 3: 222229.
  • 22
    Nelson JL. HLA relationships of pregnancy, microchimerism and autoimmune disease. J Reprod Immunol 2001; 52: 7784.
  • 23
    Willer CJ, Sadovnick AD, Ebers GC. Microchimerism in autoimmunity and transplantation: potential relevance to multiple sclerosis. J Neuroimmunol 2002; 126: 126133.
  • 24
    Gill TJ, III. Maternal-fetal interactions and disease. N Engl J Med 1993; 329: 500501.
  • 25
    Araujo MB, Leonardi LS, Boin IF, Leonardi MI, Magna LA, Donadi EA, et al. Development of donor-specific microchimerism in liver transplant recipient with HLA-DRB1 and -DQB1 mismatch related to rejection episodes. Transplant Proc 2004; 36: 953955.
  • 26
    van Kampen CA, van de LP, Duinkerken G, van Schip JJ, Roelen DL, Keymeulen B, et al. Alloreactivity against repeated HLA mismatches of sequential islet grafts transplanted in non-uremic type 1 diabetes patients. Transplantation 2005; 80: 118126.
  • 27
    Soler MJ, Mir M, Rodriguez E, Orfila A, Munne A, Vazquez S, et al. Recurrence of IgA nephropathy and Henoch-Schonlein purpura after kidney transplantation: risk factors and graft survival. Transplant Proc 2005; 37: 37053709.
  • 28
    Yoshida EM, Devonshire VA, Prout AJ. Remission of multiple sclerosis post–liver transplantation. Can J Neurol Sci 2004; 31: 539541.
  • 29
    Lohse AW, Otto G, Hermann E, Poralla T, Meyer Zum Buschenfelde KH. Remission of severe rheumatoid arthritis following liver transplantation. Br J Rheumatol 1993; 32: 827828.